{"content":[{"text":"6207FR DuPont Page 2 \n Material Safety Data Sheet \n (HAZARDS IDENTIFICATION - Continued) \n frostbite. Significant skin permeation, and systemic \n toxicity, after contact appears unlikely. There are no \n reports of human sensitization. \n \"Frostbite-like\" effects may occur if liquid or escaping \n vapors contact the eyes. \n Increased susceptibility to the effects of overexposure to \n this product may be observed in persons with pre-existing \n disease of the central nervous system or cardiovascular \n system. \n Carcinogenicity Information \n None of the components present in this material at concentrations \n equal to or greater than 0.1% are listed by IARC, NTP, OSHA or ACGIH \n as a carcinogen. \n ---------------------------------------------------------------------- \n FIRST AID MEASURES \n ---------------------------------------------------------------------- \n First Aid \n INHALATION \n If inhaled, immediately remove to fresh air. Keep person calm. \n If not breathing, give artificial respiration. If breathing is \n difficult, give oxygen. Call a physician. \n SKIN CONTACT \n Flush area with lukewarm water. Do not use hot water. If \n frostbite has occurred, call a physician. \n EYE CONTACT \n In case of contact, immediately flush eyes with plenty of water \n for at least 15 minutes. Call a physician. \n INGESTION \n Ingestion is not considered a potential route of exposure. \n Notes to Physicians \n Because of possible disturbances of cardiac rhythm, catecholamine \n drugs, such as epinephrine, should only be used with special \n caution in situations of emergency life support.","bbox":{"left":0.127451,"top":0.078194,"width":0.6862750000000001,"height":0.674243}}],"images_bbox":[],"images_bbox_not_text_overlap":[]}